Obregón M J, Calvo R, Hernández A, Escobar del Rey F, Morreale de Escobar G
Unidad de Endocrinología Molecular, Consejo Superior de Investigaciones Científicas, Madrid, Spain.
Endocrinology. 1996 Nov;137(11):4721-9. doi: 10.1210/endo.137.11.8895339.
We studied the regulation of type II 5'-deiodinase (5'D-II) activity and uncoupling protein (UCP) messenger RNA (mRNA) by thyroid hormones in fetal brown adipose tissue (BAT). Fetuses were obtained from hypothyroid pregnant rats infused with increasing doses of T4 or T3. Infusion of T4 into hypothyroid pregnant rats increased T4 and T3 concentrations and inhibited 5'D-II activity in fetal BAT. In contrast, infusion of T3 increased BAT 5'D-II activities at low, normal, or high BAT T3 concentrations. The relationship between thyroid hormone concentrations in fetal BAT and plasma showed that BAT T3 concentrations are relatively stable, increasing less than 2-fold over a wide range of circulating T4 (3-fold) or T3 (8-fold) concentrations. Most T3 in fetal BAT are locally derived from T4 and not from plasma T3. UCP mRNA expression decreased to 30% of control values in hypothyroid fetuses. UCP mRNA levels were restored to normal in parallel with BAT T3 concentrations after the infusion of either T4 or T3. UCP mRNA levels correlate well with BAT T3 concentrations. Supraphysiological doses of T4 did not further increase either BAT T3 or UCP mRNA levels. T3 might regulate basal UCP mRNA expression during fetal life.
我们研究了甲状腺激素对胎儿棕色脂肪组织(BAT)中II型5'-脱碘酶(5'D-II)活性和解偶联蛋白(UCP)信使核糖核酸(mRNA)的调节作用。从甲状腺功能减退的怀孕大鼠获取胎儿,并向其注入递增剂量的T4或T3。向甲状腺功能减退的怀孕大鼠注入T4会增加T4和T3浓度,并抑制胎儿BAT中的5'D-II活性。相比之下,在低、正常或高的BAT T3浓度下,注入T3都会增加BAT的5'D-II活性。胎儿BAT与血浆中甲状腺激素浓度之间的关系表明,BAT中的T3浓度相对稳定,在广泛的循环T4(3倍)或T3(8倍)浓度范围内,其增加幅度小于2倍。胎儿BAT中的大多数T3是在局部由T4产生,而非来自血浆T3。甲状腺功能减退胎儿的UCP mRNA表达降至对照值的30%。注入T4或T3后,UCP mRNA水平与BAT T3浓度平行恢复正常。UCP mRNA水平与BAT T3浓度密切相关。超生理剂量的T4并未进一步增加BAT T3或UCP mRNA水平。T3可能在胎儿期调节基础UCP mRNA表达。